clinical trial · NCT04997005
The Medacta International AMIStem-P Post-Marketing Surveillance Study
Medacta International SA·—·active not recruiting·n = 550
ArthrosisTraumatic ArthritisRheumatoid PolyarthritisCongenital Hip DysplasiaAvascular Necrosis of the Femoral HeadAMIStem-P
brief summary
This is a Post-Market Surveillance study of AMIStem-P femoral stem prosthesis
started
Apr 26, 2019
primary completion
Apr 30, 2029
completion
Dec 31, 2032
last updated
May 8, 2025
official title
Prospective, Multicentre, Open Study Evaluating the Performance and Stability of the AMIStem-P Femoral Stem
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol